On Wednesday, July 29, 2020, from 12:15 pm to 1:15 pm Eastern Time, the FDA will host a virtual Town Hall for clinical laboratories and commercial manufacturers that are developing or have developed diagnostic tests for SARS-CoV-2. During this Town Hall, the FDA will answer technical questions about the development and validation of tests for SARS-CoV-2. For more details, visit FDA.
Oxford Scientists Develop Extremely Rapid Diagnostic for Covid-19
October 16, 2020
NeuMoDx SARS-Cov-2 Assay Receives FDA EUA
April 6, 2020
AMP Commends Congress for Nixing VALID Act
December 26, 2022